销售-话题@MedSci

#销售#

155篇内容 | 3149人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1687376, encodeId=e9bb168e37651, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=不得担任销售，必须备案！300万医药代表迎来大整顿, objectType=article, longId=196128, objectId=4e1e19612876, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e1e19612876, replyNumber=0, likeNumber=81, createdTime=2020-09-24, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e1e19612876, moduleTitle=不得担任销售，必须备案！300万医药代表迎来大整顿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e1e19612876)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687378, encodeId=f566168e378f6, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=Moderna的COVID-19疫苗销售额可能达到50亿美元或更高, objectType=article, longId=197609, objectId=8bed19e609bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8bed19e609bf, replyNumber=0, likeNumber=74, createdTime=2021-04-27, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8bed19e609bf, moduleTitle=Moderna的COVID-19疫苗销售额可能达到50亿美元或更高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8bed19e609bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687382, encodeId=e9b5168e382cd, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=2019年全球免疫学领域销售额TOP20的制药公司, objectType=article, longId=203208, objectId=fc1c203208e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fc1c203208e3, replyNumber=0, likeNumber=94, createdTime=2021-09-18, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fc1c203208e3, moduleTitle=2019年全球免疫学领域销售额TOP20的制药公司, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fc1c203208e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687379, encodeId=a522168e37969, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=超20亿，连花清瘟上半年销售业绩公布, objectType=article, longId=201110, objectId=4e6e201110b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e6e201110b7, replyNumber=0, likeNumber=79, createdTime=2021-05-25, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e6e201110b7, moduleTitle=超20亿，连花清瘟上半年销售业绩公布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e6e201110b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687366, encodeId=4b20168e366e2, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=4.56亿美元，吉利德CAR-T疗法Yescarta2019年销售业绩披露, objectType=article, longId=187885, objectId=d23418e8852c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d23418e8852c, replyNumber=0, likeNumber=67, createdTime=2020-08-24, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d23418e8852c, moduleTitle=4.56亿美元，吉利德CAR-T疗法Yescarta2019年销售业绩披露, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d23418e8852c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687359, encodeId=c3f7168e35906, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=BTK抑制剂ONO-4059寻求在日本的生产和销售许可，用于治疗华氏巨球蛋白血症和淋巴浆细胞性淋巴瘤, objectType=article, longId=183717, objectId=9ef0183e173f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ef0183e173f, replyNumber=0, likeNumber=81, createdTime=2020-03-02, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ef0183e173f, moduleTitle=BTK抑制剂ONO-4059寻求在日本的生产和销售许可，用于治疗华氏巨球蛋白血症和淋巴浆细胞性淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ef0183e173f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687368, encodeId=6f3b168e3686d, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=解禁！退烧止咳药，开始恢复销售, objectType=article, longId=188754, objectId=c043188e5490, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c043188e5490, replyNumber=0, likeNumber=82, createdTime=2020-04-20, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c043188e5490, moduleTitle=解禁！退烧止咳药，开始恢复销售, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c043188e5490)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687375, encodeId=6503168e3759d, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=江苏连云港“药神”案二审宣判：从“销售假药”改判“非法经营”, objectType=article, longId=195266, objectId=3b54195266b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b54195266b8, replyNumber=0, likeNumber=49, createdTime=2020-06-24, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b54195266b8, moduleTitle=江苏连云港“药神”案二审宣判：从“销售假药”改判“非法经营”, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b54195266b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687377, encodeId=2957168e377b7, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=这些中药饮片，禁止生产销售, objectType=article, longId=196271, objectId=3a0d1962e11f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a0d1962e11f, replyNumber=0, likeNumber=79, createdTime=2021-03-13, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a0d1962e11f, moduleTitle=这些中药饮片，禁止生产销售, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a0d1962e11f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687364, encodeId=fa95168e3640b, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=欧洲药品管理局接受GSK靶向BCMA的抗体偶联药物belantamab mafodotin的销售授权申请, objectType=article, longId=187393, objectId=e5f218e3936c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5f218e3936c, replyNumber=0, likeNumber=85, createdTime=2020-09-04, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5f218e3936c, moduleTitle=欧洲药品管理局接受GSK靶向BCMA的抗体偶联药物belantamab mafodotin的销售授权申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5f218e3936c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687369, encodeId=762c168e36933, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=百济神州抗PD-1抗体药物替雷利珠单抗注射液正式处方销售，开启免疫治疗结构优化新时代, objectType=article, longId=189508, objectId=d6db18950878, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6db18950878, replyNumber=0, likeNumber=98, createdTime=2020-08-06, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6db18950878, moduleTitle=百济神州抗PD-1抗体药物替雷利珠单抗注射液正式处方销售，开启免疫治疗结构优化新时代, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d6db18950878)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687348, encodeId=63da168e348a0, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=两个国产PD-1的全新销售数据公布，进入医保有望吗, objectType=article, longId=178495, objectId=c4511e849581, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4511e849581, replyNumber=0, likeNumber=84, createdTime=2020-06-08, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4511e849581, moduleTitle=两个国产PD-1的全新销售数据公布，进入医保有望吗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4511e849581)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687350, encodeId=3b6a168e35046, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=终止与Lexicon合作，重磅产品销售下滑赛诺菲糖尿病业务靠谁崛起？, objectType=article, longId=179740, objectId=2fb01e974038, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2fb01e974038, replyNumber=0, likeNumber=71, createdTime=2020-01-25, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2fb01e974038, moduleTitle=终止与Lexicon合作，重磅产品销售下滑赛诺菲糖尿病业务靠谁崛起？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2fb01e974038)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687361, encodeId=30b6168e3619e, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=宁夏破获一起生产销售假药案受害人群涉及6国, objectType=article, longId=184558, objectId=3f29184558a7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3f29184558a7, replyNumber=0, likeNumber=76, createdTime=2020-10-04, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3f29184558a7, moduleTitle=宁夏破获一起生产销售假药案受害人群涉及6国, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3f29184558a7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687353, encodeId=8398168e35392, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=BMJ：酒类很低销售限价与酒精消费, objectType=article, longId=180112, objectId=aedf18011289, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aedf18011289, replyNumber=0, likeNumber=69, createdTime=2020-03-28, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aedf18011289, moduleTitle=BMJ：酒类很低销售限价与酒精消费, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aedf18011289)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687351, encodeId=e265168e35168, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=存在致癌风险！新加坡叫停8种胃酸药销售, objectType=article, longId=179741, objectId=81941e97410a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=81941e97410a, replyNumber=0, likeNumber=65, createdTime=2019-12-20, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=81941e97410a, moduleTitle=存在致癌风险！新加坡叫停8种胃酸药销售, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=81941e97410a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687349, encodeId=61e0168e34936, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=一批药企，销售费用暴涨, objectType=article, longId=179190, objectId=0cc61e9190d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0cc61e9190d5, replyNumber=0, likeNumber=77, createdTime=2019-12-22, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0cc61e9190d5, moduleTitle=一批药企，销售费用暴涨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0cc61e9190d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687370, encodeId=d413168e370d6, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=美国FDA向七家公司发出警告：严禁销售防治新冠肺炎保健品！, objectType=article, longId=190113, objectId=df98190113f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df98190113f1, replyNumber=0, likeNumber=72, createdTime=2021-01-20, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df98190113f1, moduleTitle=美国FDA向七家公司发出警告：严禁销售防治新冠肺炎保健品！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df98190113f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687339, encodeId=7883168e339f6, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=又一地放开药店处方药销售鼓励处方外流, objectType=article, longId=165663, objectId=7e181656631d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e181656631d, replyNumber=0, likeNumber=84, createdTime=2020-01-20, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e181656631d, moduleTitle=又一地放开药店处方药销售鼓励处方外流, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e181656631d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1687371, encodeId=3f6d168e37164, content=<a href='/topic/show?id=df72966659b' target=_blank style='color:#2F92EE;'>#销售#</a>, objectTitle=新冠肺炎疫情期间：瑞士限制止痛药的销售, objectType=article, longId=190510, objectId=fb7a19051044, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb7a19051044, replyNumber=0, likeNumber=69, createdTime=2021-01-20, rootId=0, userName=1249862am81(暂无昵称), userId=0bca28361924, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb7a19051044, moduleTitle=新冠肺炎疫情期间：瑞士限制止痛药的销售, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb7a19051044)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

销售

2020-05-29

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

不得担任销售，必须备案！300万医药代表迎来大整顿

2020-09-24

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

Moderna的COVID-19疫苗销售额可能达到50亿美元或更高

2021-04-27

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

2019年全球免疫学领域销售额TOP20的制药公司

2021-09-18

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

超20亿，连花清瘟上半年销售业绩公布

2021-05-25

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

4.56亿美元，吉利德CAR-T疗法Yescarta2019年销售业绩披露

2020-08-24

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

BTK抑制剂ONO-4059寻求在日本的生产和销售许可，用于治疗华氏巨球蛋白血症和淋巴浆细胞性淋巴瘤

2020-03-02

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

解禁！退烧止咳药，开始恢复销售

2020-04-20

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

江苏连云港“药神”案二审宣判：从“销售假药”改判“非法经营”

2020-06-24

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

这些中药饮片，禁止生产销售

2021-03-13

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

欧洲药品管理局接受GSK靶向BCMA的抗体偶联药物belantamab mafodotin的销售授权申请

2020-09-04

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

百济神州抗PD-1抗体药物替雷利珠单抗注射液正式处方销售，开启免疫治疗结构优化新时代

2020-08-06

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

两个国产PD-1的全新销售数据公布，进入医保有望吗

2020-06-08

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

终止与Lexicon合作，重磅产品销售下滑赛诺菲糖尿病业务靠谁崛起？

2020-01-25

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

宁夏破获一起生产销售假药案受害人群涉及6国

2020-10-04

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

BMJ：酒类很低销售限价与酒精消费

2020-03-28

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

存在致癌风险！新加坡叫停8种胃酸药销售

2019-12-20

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

一批药企，销售费用暴涨

2019-12-22

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

美国FDA向七家公司发出警告：严禁销售防治新冠肺炎保健品！

2021-01-20

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

又一地放开药店处方药销售鼓励处方外流

2020-01-20

1249862am81(暂无昵称) (审核中...)

前往app查看评论内容

#销售#

新冠肺炎疫情期间：瑞士限制止痛药的销售

2021-01-20

科室
- - 订阅+
  - 更多科室
工具
服务